Safety assessment of novel devices - Digital Innovation Hubs

Description

We carry out safety assessment of novel devices as well as chemicals, drugs, nutrients, nanomaterials, environmental and other compounds. Our range of toxicity assays for cytotoxicity, genotoxicity, mutagenicity, carcinogenicity, DNA damage and repair is backed by the leading researchers in these fields.

This is a service of

Norgenotech AS

https://norgenotech.no/
Oslo Cancer Cluster, Radiumhospitalet, Ullernchausseén 64/66, 0379 Oslo, Norway
Incorporated Entity

Service url: https://norgenotech.no/assays/
Typical users: • Research laboratories engaged in studies of DNA damage and repair • Chemical industry (in EU testing enforced by REACH) • Nanomaterials industry • Cosmetic and pharmaceutical industries • Contract research (chemical, clinical and specialized genotoxicity testing labs) • Food industry (regulated by European Food Safety Authority, EFSA) • Environmental monitoring organisations • Regulators • Precision medical diagnostics: medical testing laboratories
Financial modal: Paid service
Limit: No
Region: Global
Developed for H2020 EIT or another EU project: Partially
Operational since: 2010

Service category

Testing Facilities and Test Centers
- Academic or contract research labs offering healthcare robotics and related technology development support